Here's how Houston ranks on annual list of greenest cities in the US

room for improvement

Yikes, Houston is very far from being considered among the greenest cities in the country. Photo via Getty Images

Bad news, Houston. The Bayou City is the third worst metro when it comes to the country's greenest cities.

According to WalletHub's recently released Greenest Cities in America report, Houston is No. 98 out of 100 of the largest cities that were ranked in the study, which was based on information from the U.S. Census Bureau, U.S. Environmental Protection Agency, The Trust for Public Land, U.S. Department of Energy - The Alternative Fuels Data Center, and more.

“There are plenty of things that individuals can do to adopt a green lifestyle, from recycling to sharing rides to installing solar panels on their homes. However, living in one of the greenest cities can make it even easier to care for the environment, due to sustainable laws and policies, access to locally-grown produce and infrastructure that allows residents to use vehicles less often," says Chip Lupo, WalletHub Analyst. "The greenest cities also are better for your health due to superior air and water quality.”

Houston scored 36.88 points out of 100, and comes in dead last on the environment ranking. Here's how the city performs when it comes to the other metrics:

No. 87 for transportation
No. 52 for energy sources
No. 61 for lifestyle and policy
No. 91 for greenhouse-gas emissions per capita
No. 30 for percent of green space
No. 86 for median air quality index
No. 97 for annual excess fuel consumption
No. 56 for percent of commuters who drive
No. 39 for walk score
No. 33 for farmers markets per capita

The big winners on the report are mostly on the West Coast. Of the top 10, six cities are from California. These are the greenest cities, per the report:

San Diego, California
Washington, D.C.
Honolulu, Hawaii
San Francisco, California
San Jose, California
Seattle, Washington
Oakland, California
Portland, Oregon
Fremont, California
Irvine, California

Texas isn't seen on the list until Austin, which ranked No. 26. The rest of the major Lone Star State major metros include San Antonio at No. 44, Fort Worth at No. 76, and Dallas at No. 81.While this report is pretty damning, there's not a general consensus that all hope is lost for Houston when it comes to being green. Last year, the city was ranked as having the lowest carbon footprint, based on a report from Park Sleep Fly.

However, WalletHub's report has pretty consistently ranked Houston low on the list. Last year, Houston was slightly higher up at No. 95. In 2022 and 2021, the city claimed the No. 93 spot.

------

This article originally ran on EnergyCapital.

From Your Site Articles

Houston tied with five other cities for the worst greenhouse gas emissions.. Photo via Getty Images

Report: Here's how Houston ranks among the country's greenest cities

Seeing green

Houston may be the energy capital of the world, but it apparently isn't the capital of "greenness."

The Bayou City lands at No. 93 among the 100 largest U.S. cities in a new WalletHub ranking of the country's greenest places. Houston held the same spot in last year's ranking. Aside from being the eighth worst city in the 2021 study, Houston is the lowest-ranked city in Texas.

To determine the cities promoting an environmentally friendly lifestyle, WalletHub compared the 100 largest cities across 28 key "green" indicators. Those factors include greenhouse gas emissions per capita, number of smart energy policies and initiatives, and green job opportunities.

Unfortunately, Houston's overall showing isn't impressive. Here is a sampling, with No. 1 being best, No. 50 being average, and No. 100 being worst:

Excess fuel consumption per year, No. 97.
Greenhouse gas emissions per capita, No. 94. Houston tied with five other cities for the worst greenhouse gas emissions.
Median air quality index, No. 72.
Share of commuters who drive, No. 54.
Percentage of green space, No. 37.
Farmers markets per capita, No. 35.
Walkability, No. 34.

Here is how other Texas cities fared:

Austin, No. 26.
Garland, No. 44.
San Antonio, No. 46
Laredo, No. 68.
El Paso, No. 69.
Irving, No. 74.
Plano, No. 79.
Lubbock, No. 83.
Arlington, No. 85.
Dallas, No. 89.
Corpus Christi, No. 90.

San Diego tops the WalletHub list.As Houston hangs out toward the bottom of the WalletHub ranking, government and business leaders in the region are striving to make Houston greener.

For instance, the City of Houston in August launched a pilot project that will speed up the permitting process for environmentally friendly stormwater projects.

And just this month, Houston Mayor Sylvester Turner declared October 6 as Energy Efficiency Day. The occasion encouraged residents and businesses to support the city's clean energy goals. "Implementing energy efficiency measures is the cheapest, fastest, and cleanest way to reduce Houston's energy demand," the mayor's office says.

In a news release, Laura Patiño, the city's interim chief resilience officer, says Houston must come up with solutions to combat climate change, ensure a "just and equitable" transition to clean energy, and "promote economic growth in an inclusive and transparent manner."

Despite the poor performance in the WalletHub study, Houston continues to make headway in green energy.

For example, Turner in August touted Houston's status as the No. 1 municipal entity in the U.S. for the most annual consumption of power from renewable sources. The U.S. Environmental Protection Agency (EPA) list features participants in its Green Energy Partnership.

In a news release, Turner said the EPA recognition is "great news for the city of Houston and, by extension, for the rest of the world. We are going big to set the example for cities around the world. If 100 percent renewable energy can happen in Houston, it can happen in any other city."

Ad Placement 300x100

Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston digital health platform Koda lands strategic investment

money moves

Houston-based advance care planning platform Koda Health has added another investor to the lineup.

The company secured a strategic investment for an undisclosed amount from UPMC Enterprises, the commercialization arm of the University of Pittsburgh Medical Center. The funding is part of Koda's oversubscribed series A funding round that closed in October, according to a release.

"UPMC Enterprises’ investment is a meaningful signal, not just to Koda, but to the broader market," Dr. Desh Mohan, chief medical officer and co-founder of Koda Health, said in the news release. "It validates that health systems are ready to invest in infrastructure that makes advance care planning work the way it should: proactively, at scale, and with the human support that these conversations require. Having UPMC Enterprises as a strategic investor puts us in a unique position to prove what's possible."

Koda has raised $14 million to date, according to a representative from the company. Its series A round was led by Evidenced, with participation from Mudita Venture Partners, Techstars and the Texas Medical Center last year. At the time, the company said the funding would allow it to scale operations and expand engineering, clinical strategy and customer success. The company described the round as a "pivotal moment," as it had secured investments from influential leaders in the healthcare and venture capital space.

Koda Health, which was born out of the TMC's Biodesign Fellowship in 2020, saw major growth last year, as well, and now supports more than 1 million patients nationwide through partnerships with Cigna Healthcare, Privia Health, Guidehealth, Sentara, UPMC and Memorial Hermann Health System.

The company integrated its end-of-life care planning platform with Dallas-based Guidehealth in April 2025 and with Epic Systems in July 2025. It also won the 2025 Houston Innovation Award in the Health Tech Business category. Read more here.

UH med school gets $2M gift and more top Houston innovation news

Trending Topics

Editor's note: The top Houston innovation news of the month is full of fresh funding, with two Texas medical schools receiving major gifts — one of historic proportions. Below are the five most-read InnovationMap headlines from April 16-30, 2026.

UH med school granted $2M gift to offer student scholarships

A new scholarship endowment aims to support students in the University of Houston’s recently established medical school. The University of Houston’s Tilman J. Fertitta Family College of Medicine received a planned estate gift commitment estimated at $2.1 million to establish the Bob Diehl and Teresa Evans Diehl Scholarship Endowment. The scholarship will assist full-time medical students who demonstrate financial need and meet academic standards. Continue reading.

How Houston innovators played a role in the historic Artemis II splashdown

Research from Rice University played a critical role in the safe return of U.S. astronauts aboard NASA’s Artemis II mission this month. Rice mechanical engineer Tayfun E. Tezduyar and longtime collaborator Kenji Takizawa developed a key computational parachute fluid-structure interaction (FSI) analysis system that proved vital in NASA’s Orion capsule’s descent into the Pacific Ocean. The FSI system, originally developed in 2013 alongside NASA Johnson Space Center, was critical in Orion’s three-parachute design, which slowed the capsule as it returned to Earth, according to Rice. Continue reading.

Baylor scientist lands $2M grant to explore links between viruses and Alzheimer’s

A Baylor College of Medicine scientist will begin exploring the possible link between Alzheimer’s disease and viral infections thanks to a $2 million grant awarded in March. Dr. Ryan S. Dhindsa hypothesizes that Alzheimer’s may have some link to previous viral infections contracted by the patient. To study this intriguing possibility, the American Brain Foundation has gifted him the Cure One, Cure Many award in neuroinflammation. Continue reading.

New UT Austin med center, anchored by MD Anderson, gets historic gift

A donation announced April 21 breaks a major record at the University of Texas at Austin. Michael and Susan Dell are now UT Austin's first supporters to give $1 billion. In response, the university will create the UT Dell Campus for Advanced Research and the UT Dell Medical Center to "advance human health," per a press release. Continue reading.

Houston VC funding surged nearly 50% in Q1 2026, report says

Houston saw a jump in VC funding in Q1 2026, fueled by several major investments in clean energy startups. Image via Getty Images

First-quarter venture capital funding for Houston-area startups climbed nearly 50 percent compared to the same time last year, according to the PitchBook-NVCA Venture Monitor. In Q1 2026, Houston-area startups raised $532.3 million, a 49 percent jump from $320.2 million in Q1 2025, according to the PitchBook-NVCA Venture Monitor. However, the Q1 total fell 23 percent from the $671.05 million raised in Q4 2025. Continue reading.

New 'living pharmacy' biotech company launches out of Rice venture studio

fighting cancer

Rice University’s biotech venture studio RBL LLC has launched a new “living pharmacy” company, Duracyte, designed to make cancer treatment easier on patients.

Backed by an up to $45 million Advanced Research Projects Agency for Health (ARPA-H) award, Duracyte aims to commercialize implantable biohybrid pharmacy devices that are designed to produce therapeutic proteins inside the human body around the clock, replacing the need for regular injections and infusions for some cancer patients.

The company’s main platform is its Hybrid Advanced Molecular Manufacturing Regulator (HAMMR), a rechargeable, implantable device that can sense biological signals, monitor tumor environments and adjust therapeutic output in real time. HAMMR has wireless communication capabilities, which allow patients and clinicians to remotely monitor results through an app every five minutes and make changes to treatment plans without a hosptial visit. Additionally, the device can generate its own oxygen supply, which is key for the therapeutic cells’ survival.

“Biologic medicines such as monoclonal antibodies, cytokines and metabolic regulators already account for a significant share of modern therapeutics, but the way we deliver them today often requires frequent injections or infusions that can be demanding for patients and lead to inconsistent drug levels,” Daniel Anderson, MIT professor and co-founder of Duracyte, said in a news release. “Our vision is to enable a continuous, stable therapy by producing these medicines directly inside the body, which could improve treatment consistency, reduce side effects and ultimately transform how biologic therapies are delivered across many diseases.”

Duracyte’s first clinical trial is slated to begin by the end of 2026 and will focus on recurrent ovarian cancer. The Phase I study will build upon existing work on encapsulated cytokine pharmacy technology, and the company hopes that within a few years this treatment can reach clinical application.

The development of Duracyte is supported by ARPA-H's Targeted Hybrid Oncotherapeutic Regulation (THOR) project, which supports a multidisciplinary research consortium co-led by Omid Veiseh, a professor of bioengineering at Rice. The consortium also includes others at Rice, The University of Texas MD Anderson Cancer Center, Stanford University, Carnegie Mellon University, Northwestern University and the University of Houston, plus industry collaborators like Chicago-based CellTrans.

“What we are building is the culmination of years of progress in cell engineering, biomaterials and implantable device technology,” Veiseh added in the release. “By combining these advances with real-time sensing and adaptive drug delivery, we are working with the support of RBL to create a true ‘living pharmacy’ that can deliver continuous, precisely controlled biologic therapies and fundamentally change how these treatments reach patients.”

RBL launched in 2024 and is based out of Houston’s Texas Medical Center Helix Park. Duracyte is the third company launched by RBL, including Sentinel BioTherapeutics, a clinical-stage immunotherapy company developing localized cytokine therapies for solid tumors, and SteerBio, a regenerative medicine company targeting lymphedema.

“Duracyte exemplifies the kind of breakthrough that Houston’s ecosystem is built to produce,” Paul Wotton, managing partner of RBL LLC and co-founder of Duracyte, added in the release. “With world-class clinical infrastructure, exceptional engineering talent and initiatives like the Texas Biotech Task Force driving alignment across industry, investment and talent, this region is uniquely positioned to move the most ambitious ideas in medicine from concept to patient, faster than anywhere else.”

View All Listings

INNOVATIONMAP EMAILS ARE AWESOME